Daniel Morin, MD, FACC, FHRS, MPH
- Sr Physician, Southshore Region
- 1514 Jefferson Hwy, New Orleans, LA, 70121
For additional information or to make an appointment, click here.
Overview
Overview
- Dr. Daniel Morin graduated with honors and distinction from Cornell University in 1995, where he earned his bachelor of arts degree in biochemistry. In 2000, he earned his medical degree from the University of Massachusetts Medical School and his master of public health degree from Harvard University. He then served his internship and residency in internal medicine at Tufts-New England Medical Center in Boston, Massachusetts. Dr. Morin went on to complete advanced fellowships in cardiovascular disease and cardiac electrophysiology at New York Presbyterian Hospital-Weill Cornell Medical Center in New York City. He is board-certified in internal medicine, cardiology, and clinical cardiac electrophysiology. He is a fellow of the American College of Cardiology and the Heart Rhythm Society. Dr. Morin has served as an attending cardiologist and cardiac electrophysiologist since 2008. Dr. Morin's clinical interests are in device therapy for cardiac dysfunction (including cardiac resynchronization therapy) and treatment of cardiac arrhythmias via medical therapy and/or catheter ablation. In addition to his clinical work, Dr. Morin serves as director of electrophysiology research and director of cardiovascular research for the Ochsner Health System. He heads an active team researching such diverse subjects as risk stratification for sudden cardiac arrest, new applications for cardiac resynchronization therapy, the effects of ablation on cardiac contractility and relationships between the environment and cardiac tachyarrhythmias. He has published peer-reviewed scientific papers, including in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology, European Journal of Cardiology, and Heart Rhythm. Dr. Morin is associate editor of several medical journals and served as the inaugural online editor of the journal Heart Rhythm for five years. In 2020, Dr. Morin was promoted to the academic title of professor at University of Queensland - Ochsner Clinical School.
Publications
Selected publications
-
2023Use of a New Standardized Unfractionated Heparin Protocol for Left-Sided Ablation Procedures Improves Time in the Therapeutic ACT Range. Journal of Cardiothoracic and Vascular Anesthesia. 38:67-72.
-
2023Which should you choose for post operative atrial fibrillation, carvedilol or metoprolol? A systemic review and meta-analysis. Current Problems in Cardiology. 49.
-
2023Worldwide survey on implantation of and outcomes for conduction system pacing with His bundle and left bundle branch area pacing leads. Journal of Interventional Cardiac Electrophysiology. 66:1589-1600.
-
2023(Left) Bundle Up! It's Getting Cold Out There in the Coronary Sinus. Journal of the American College of Cardiology. 82:242-244.
-
2023Risk of ventricular arrhythmias following implantable cardioverter-defibrillator generator change in patients with recovered ejection fraction: Implications for shared decision-making. Journal of Cardiovascular Electrophysiology.
-
2023Effect of sacubitril-valsartan on the incidence of atrial fibrillation: A meta-analysis. Journal of Cardiovascular Electrophysiology.
-
2023IMPACT OF RB-82 INFUSION PROFILE ON IMAGE QUALITY OF MYOCARDIAL PERFUSION IMAGES. Journal of the American College of Cardiology. 81:1453-1453.
-
2023Introducing a new Heart Rhythm series: Heart Rhythm Society Committee/Council Viewpoints. Heart Rhythm. 20:322-323.
-
2022Revaluing ablation therapy: History, recent developments, and future Heart Rhythm Society strategy. Heart Rhythm. 19:1566-1568.
-
2022Revaluing ablation therapy: History, recent developments, and future Heart Rhythm Society strategy. Heart Rhythm. 19:1566-1568.
-
2022Editorial commentary: Diagnosis of pulmonary embolism: Know your strengths well, and know your weaknesses better. Trends in Cardiovascular Medicine. 32:269-270.
-
2022The ENHANCE-AF clinical trial to evaluate an atrial fibrillation shared decision-making pathway: Rationale and study design. American Heart Journal. 247:68-75.
-
2022RACE AND SEX-BASED DISPARITY IN CARE: WATCHMAN LEFT ATRIAL APPENDAGE OCCLUSION IN ATRIAL FIBRILLATION. Journal of the American College of Cardiology. 79:909-909.
-
2021Development and Validation of a Multivariable Risk Prediction Model for COVID-19 Mortality in the Southern United States. Mayo Clinic Proceedings. 96:3030-3041.
-
2021Impact of Preinfection Left Ventricular Ejection Fraction on Outcomes in COVID-19 Infection. Current Problems in Cardiology. 46.
-
2021IMPACT OF BASELINE LEFT VENTRICULAR EJECTION FRACTION ON OUTCOMES IN COVID-19 INFECTION. Journal of the American College of Cardiology. 77:3066-3066.
-
2021MEASUREMENT OF THREE-DIMENSIONAL (3D) MITRAL VALVE AREA IN PATIENTS WITH MITRAL ANNULAR CALCIFICATION BY TRANSTHORACIC ECHOCARDIOGRAPHY. Journal of the American College of Cardiology. 77:1348-1348.
-
2021Leadless and Wireless Cardiac Devices: The Next Frontier in Remote Patient Monitoring. Current Problems in Cardiology. 46.
-
2021Right ventricular lead location and outcomes among patients with cardiac resynchronization therapy: A meta-analysis. Progress in Cardiovascular Diseases. 66:53-60.
-
2021The role of atrial fibrillation catheter ablation in patients with heart failure. Progress in Cardiovascular Diseases. 66:80-85.
-
2020Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?. American Journal of Cardiovascular Drugs. 20:413-418.
-
2020BASELINE GLOBAL LEFT VENTRICULAR MYOCARDIAL WORK INDEX CAN PREDICT IMPROVEMENT IN EJECTION FRACTION IN PATIENTS WITH CLASSICAL LOW FLOW LOW GRADIENT AORTIC STENOSIS UNDERGOING TAVR. Journal of the American College of Cardiology. 75:1751-1751.
-
2020Class 1C antiarrhythmic drugs in atrial fibrillation and coronary artery disease. Journal of Cardiovascular Electrophysiology. 31:607-611.
-
2020First in human: the effects of biventricular pacing on cardiac output in severe pulmonary arterial hypertension. Heart and Vessels. 35:852-858.
-
2020In reply: Impaired myocardial blood flow in atrial fibrillation. Journal of Cardiovascular Electrophysiology. 31:1883-1883.
-
2020Positron emission tomography absolute stress myocardial blood flow for risk stratification in nonischemic cardiomyopathy. Journal of Cardiovascular Electrophysiology. 31:1137-1146.
-
2020SERIAL ECHOCARDIOGRAPHIC EVALUATION OF PATIENTS WITH DEGENERATIVE MITRAL STENOSIS UNDERGOING TAVR. Journal of the American College of Cardiology. 75:1778-1778.
-
2020THE MAZE PROCEDURE IS A RISK FACTOR FOR LEFT ATRIAL THROMBUS. Journal of the American College of Cardiology. 75:374-374.
-
2020Utility of serial measurement of biomarkers of cardiovascular stress and inflammation in systolic dysfunction. EP-Europace. 22:1044-1053.
-
2019Advances in the Risk Stratification, Prevention, and Treatment of Sudden Check for updates Cardiac Death. Progress in Cardiovascular Diseases. 62:203-204.
-
2019Editorial commentary: The Checklist Manifesto: Cardiogenic Shock Edition. Trends in Cardiovascular Medicine. 29:418-419.
-
2019HIS BUNDLE PACING USING RETROGRADE MAPPING FOR A PATIENT WITH L-TRANSPOSITION OF GREAT ARTERIES. Journal of the American College of Cardiology. 73:2880-2880.
-
2019In reply-Atrial Fibrillation and Morbidity and Mortality in Stress-Induced Cardiomyopathy. Mayo Clinic Proceedings. 94:2148-2149.
-
2019Non-arrhythmic causes of sudden death: A comprehensive review. Progress in Cardiovascular Diseases. 62:265-271.
-
2019Sudden cardiac death in Long QT syndrome (LQTS), Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT). Progress in Cardiovascular Diseases. 62:227-234.
-
2019Sudden cardiac death in nonischemic cardiomyopathy. Progress in Cardiovascular Diseases. 62:235-241.
-
2019The impact of revascularization on myocardial blood flow as assessed by positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging. 46:1226-1239.
-
2019The wearable cardioverter-defibrillator vest: Indications and ongoing questions. Progress in Cardiovascular Diseases. 62:256-264.
-
2019Who Should Receive a Wearable Defibrillator Vest at Hospital Discharge?. Current Cardiology Reports. 21.
-
2018CORONARY REVASCULARIZATION-BASED IMPROVEMENT IN REGIONAL MYOCARDIAL BLOOD FLOW IS DEPENDENT ON BASELINE REGIONAL CORONARY FLOW CAPACITY. Journal of the American College of Cardiology. 71:1493-1493.
-
2018Cost-Saving Opportunities with Appropriate Utilization of Cardiac Telemetry. American Journal of Cardiology. 122:1570-1573.
-
2018Editorial commentary: Arrhythmias in patients with left ventricular assist devices: Pump fixed; rhythm ... not so much. Trends in Cardiovascular Medicine. 28:51-52.
-
2018FIRST IN HUMAN: THE EFFECTS OF BIVENTRICULAR PACING ON CARDIAC OUTPUT IN SEVERE PULMONARY HYPERTENSION. Journal of the American College of Cardiology. 71:1922-1922.
-
2018Optimalmethod ofmeasuring the T-peak to T-end interval for risk stratification in primary prevention. EP-Europace. 20:698-705.
-
2018
-
2018Wearable Cardioverter-Defibrillator after Myocardial Infarction. New England Journal of Medicine. 379:1205-1215.
-
2017In Reply-Atrial Fibrillation: Interatrial Block May Be an Underdiagnosed and Easily Recognizable Risk Factor. Mayo Clinic Proceedings. 92:682-682.
-
2017
-
2017REDUCED FLOW CAPACITY AS MEASURED BY CARDIAC POSITRON EMISSION TOMOGRAPHY PREDICTS VENTRICULAR TACHYARRHYTHMIA IN PATIENTS WITH AN ICD. Journal of the American College of Cardiology. 69:1607-1607.
-
2017The effect of coronary revascularization on regional myocardial blood flow as assessed by stress positron emission tomography. Journal of Nuclear Cardiology. 24:961-974.
-
2017Time-varying circulating biomarkers predict ventricular tachyarrhythmia and death: the LIFEMARKER-VT study. European Heart Journal. 38:1377-1377.
-
2016Evaluating the benefits of home-based management of atrial fibrillation: current perspectives. Pragmatic and Observational Research. 7:41-53.
-
2016Ochsner Journal Focus Issue: Cardiovascular Diseases. The Ochsner Journal. 16:193-193.
-
2016Predicting Persistent Left Ventricular Dysfunction Following Myocardial Infarction The PREDICTS Study. Journal of the American College of Cardiology. 67:1186-1196.
-
2016Surface Electrocardiogram Predictors of Sudden Cardiac Arrest. The Ochsner Journal. 16:280-289.
-
2016TELEMETRY OVERUSE AND ITS ECONOMIC IMPLICATIONS. Journal of the American College of Cardiology. 67:1993-1993.
-
2016The State of the Art: Atrial Fibrillation Epidemiology, Prevention, and Treatment. Mayo Clinic Proceedings. 91:1778-1810.
-
2015A little Red Bull may give you wings, but it probably will not affect your Tpe. ANATOLIAN JOURNAL OF CARDIOLOGY. 15:923-924.
-
2015Advances in the Prevention and Treatment of Atrial Fibrillation. Progress in Cardiovascular Diseases. 58:103-104.
-
2015Atrial Fibrillation and Heart Failure: Update 2015. Progress in Cardiovascular Diseases. 58:126-135.
-
2015INCIDENCE OF PACEMAKER IMPLANTATION AND PARAVALVULAR AORTIC INSUFFICIENCY AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: A COMPARISON OF THREE GENERATIONS OF EDWARDS SAPIEN VALVES. Journal of the American College of Cardiology. 65:A2034-A2034.
-
2015Lifestyle Modification in the Prevention and Treatment of Atrial Fibrillation. Progress in Cardiovascular Diseases. 58:117-125.
-
2015POSITRON EMISSION TOMOGRAPHY STRESS MYOCARDIAL BLOOD FLOW PREDICTS VENTRICULAR TACHYARRHYTHMIA IN PATIENTS WITH AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR. Journal of the American College of Cardiology. 65:A1149-A1149.
-
2014An Uncommon Cause of Pacemaker-Mediated Ventricular Tachycardia. Journal of Cardiovascular Electrophysiology. 25:107-109.
-
2014CORRELATION BETWEEN POSITRON EMISSION TOMOGRAPHY STRESS MYOCARDIAL BLOOD FLOW AND VENTRICULAR TACHYARRHYTHMIA OR DEATH IN PATIENTS WITH CARDIOMYOPATHY. Journal of the American College of Cardiology. 63:A293-A293.
-
2014Cardiac Resynchronization Therapy: History, Present Status, and Future Directions. The Ochsner Journal. 14:596-607.
-
2014Cardiometabolic Risk Factors and Atrial Fibrillation (vol 15, pg 74, 2014). Reviews in Cardiovascular Medicine. 15:74-74.
-
2014THE EFFECT OF CORONARY REVASCULARIZATION ON MYOCARDIAL BLOOD FLOW AS ASSESSED BY PET-STRESS. Journal of the American College of Cardiology. 63:A1019-A1019.
-
2013Atrial Fibrillation in the 21st Century: A Current Understanding of Risk Factors and Primary Prevention Strategies. Mayo Clinic Proceedings. 88:394-409.
-
2013Cardiometabolic Risk Factors and Atrial Fibrillation. Reviews in Cardiovascular Medicine. 14:E73-E81.
-
2012Computed tomography of a coronary sinus diverticulum associated with Wolff-Parkinson-White syndrome. Heart Rhythm. 9:1338-1339.
-
2011Progression from Concentric Left Ventricular Hypertrophy and Normal Ejection Fraction to Left Ventricular Dysfunction. American Journal of Cardiology. 108:992-996.
-
2010Iatrogenic Twiddler's Syndrome. Journal of Interventional Cardiac Electrophysiology. 29:135-137.
-
2010Usefulness of Precordial T-Wave Inversion to Distinguish Arrhythmogenic Right Ventricular Cardiomyopathy from Idiopathic Ventricular Tachycardia Arising from the Right Ventricular Outflow Tract. American Journal of Cardiology. 105:1821-1824.
-
2009Atrial Fibrillation: Current Perspective. The Ochsner Journal. 9:241-247.
-
2009Cardiac Resynchronization Therapy. The Ochsner Journal. 9:248-256.
-
2009QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study. European Heart Journal. 30:2908-2914.